Pancreatic cancer trials in Canada
58 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleUsing Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life
- Where
- Vancouver
- Age
- 18 years and over
- People
- 50
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT07255001 - No phaseTaking peopleProspectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
- Where
- Calgary, Edmonton, Ottawa, Vancouver
- Age
- 18 years and over
- People
- 190
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT02869802 - No phaseTaking peopleMonitoring and Managing Glucose Levels in People With Pancreatic Cancer
- Where
- Toronto, Vancouver
- Age
- 18 years and over
- People
- 50
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT05132244 - No phaseTaking peopleBiospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Where
- Montreal, Toronto
- Age
- Up to 17 years
- People
- 1,600 worldwide
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06651580 - Phase 2Taking peopleCessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
- Where
- Edmonton, London, Ottawa, Regina, Saskatoon, Toronto, Vancouver
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- Australasian Gastro-Intestinal Trials Group
See details and how to joinNCT06345079 - No phaseTaking peopleComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Where
- Hamilton, Kingston, New Westminster, Toronto
- Age
- 50 years to 75 years
- People
- 770 worldwide
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT04239573 - Phase 3Taking peopleTesting Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Where
- Edmonton
- Age
- 18 years and over
- People
- 356 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT06958328 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Edmonton, Hamilton, Montreal, Ottawa, Toronto, Vancouver
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Edmonton, Montreal, Toronto
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - No phaseTaking peopleSimulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
- Where
- Toronto
- Age
- 18 years and over
- People
- 5
- Run by
- University Health Network, Toronto
See details and how to joinNCT07636382 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Montreal, Toronto
- Age
- 18 years to 100 years
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Montreal, Toronto
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Montreal, Ottawa, Toronto
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 1Taking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Ottawa, Toronto
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - Phase 2Taking peopleSafely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Where
- Edmonton
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Endevica Bio
See details and how to joinNCT06937177 - Phase 1/2Not yet taking people in CanadaSamuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer
- Where
- Toronto
- Age
- 18 years and over
- People
- 67
- Run by
- University Health Network, Toronto
See details and how to joinNCT07665684 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Calgary, Montreal, Toronto
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - Phase 2Taking peopleUsing Tumor Models to Determine Treatments
- Where
- Toronto
- Age
- 18 years and over
- People
- 25
- Run by
- University Health Network, Toronto
See details and how to joinNCT06813079 - No phaseTaking peopleMarathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Where
- Kingston, Ottawa, Toronto
- Age
- 18 years and over
- People
- 500
- Run by
- University Health Network, Toronto
See details and how to joinNCT05403177 - Phase 1Taking peopleStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Where
- Montreal, Toronto
- Age
- 18 years and over
- People
- 52 worldwide
- Run by
- Senhwa Biosciences, Inc.
See details and how to joinNCT04890613 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Toronto, Vancouver
- Age
- 18 years and over
- People
- 252 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07223047 - Phase 2Taking peopleA Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
- Where
- Montreal, Toronto
- Age
- 18 years and over
- People
- 43
- Run by
- University Health Network, Toronto
See details and how to joinNCT06453486 - No phaseTaking peopleMR Guidance for Liver and Pancreas
- Where
- Toronto
- Age
- 18 years and over
- People
- 30
- Run by
- University Health Network, Toronto
See details and how to joinNCT03582189 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Toronto
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 1/2Taking peoplePhase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
- Where
- Toronto
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- Auricula Biosciences Inc.
See details and how to joinNCT07148128